Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Mortality and poststroke depression: a placebo-controlled trial of antidepressants.

Jorge RE, Robinson RG, Arndt S, Starkstein S.

Am J Psychiatry. 2003 Oct;160(10):1823-9.

PMID:
14514497
2.

Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.

Robinson RG, Schultz SK, Castillo C, Kopel T, Kosier JT, Newman RM, Curdue K, Petracca G, Starkstein SE.

Am J Psychiatry. 2000 Mar;157(3):351-9.

PMID:
10698809
3.

Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up.

Narushima K, Kosier JT, Robinson RG.

J Nerv Ment Dis. 2002 May;190(5):296-303.

PMID:
12011609
4.

Risk factors for and correlates of poststroke depression following discontinuation of antidepressants.

Fiedorowicz JG, Takezawa K, Robinson RG.

J Neuropsychiatry Clin Neurosci. 2007 Fall;19(4):399-405.

PMID:
18070842
5.
6.

Effect of antidepressants on the course of disability following stroke.

Mikami K, Jorge RE, Adams HP Jr, Davis PH, Leira EC, Jang M, Robinson RG.

Am J Geriatr Psychiatry. 2011 Dec;19(12):1007-15. doi: 10.1097/JGP.0b013e31821181b0.

7.

Aggressive behavior in patients with stroke: association with psychopathology and results of antidepressant treatment on aggression.

Chan KL, Campayo A, Moser DJ, Arndt S, Robinson RG.

Arch Phys Med Rehabil. 2006 Jun;87(6):793-8.

PMID:
16731214
8.

Antidepressant treatment for postnatal depression.

Molyneaux E, Howard LM, McGeown HR, Karia AM, Trevillion K.

Cochrane Database Syst Rev. 2014 Sep 11;9:CD002018. doi: 10.1002/14651858.CD002018.pub2. Review.

PMID:
25211400
9.

Selective serotonin reuptake inhibitor treatment and depression are associated with poststroke mortality.

Ried LD, Jia H, Feng H, Cameon R, Wang X, Tueth M, Wu SS.

Ann Pharmacother. 2011 Jul;45(7-8):888-97. doi: 10.1345/aph.1P478. Epub 2011 Jul 12.

PMID:
21750310
10.

Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression.

Akhondzadeh S, Faraji H, Sadeghi M, Afkham K, Fakhrzadeh H, Kamalipour A.

J Clin Pharm Ther. 2003 Oct;28(5):379-84.

PMID:
14632962
11.

Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.

Joyce PR, Mulder RT, Luty SE, Sullivan PF, McKenzie JM, Abbott RM, Stevens IF.

Aust N Z J Psychiatry. 2002 Jun;36(3):384-91.

PMID:
12060188
12.
13.

Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy.

Dam M, Tonin P, De Boni A, Pizzolato G, Casson S, Ermani M, Freo U, Piron L, Battistin L.

Stroke. 1996 Jul;27(7):1211-4.

14.

Fluoxetine improves the quality of life in patients with poststroke emotional disturbances.

Choi-Kwon S, Choi J, Kwon SU, Kang DW, Kim JS.

Cerebrovasc Dis. 2008;26(3):266-71. doi: 10.1159/000147454. Epub 2008 Jul 23.

PMID:
18648199
15.

Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.

Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT Jr, Pollock BG, Gaffney A, Narayan M, Finkel MS, McCafferty J, Gergel I.

JAMA. 1998 Jan 28;279(4):287-91.

PMID:
9450712
16.

Long-term outcomes of initial antidepressant drug choice in a "real world" randomized trial.

Simon GE, Heiligenstein J, Revicki D, VonKorff M, Katon WJ, Ludman E, Grothaus L, Wagner E.

Arch Fam Med. 1999 Jul-Aug;8(4):319-25.

PMID:
10418538
17.

Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.

Wong ML, Dong C, Flores DL, Ehrhart-Bornstein M, Bornstein S, Arcos-Burgos M, Licinio J.

Am J Psychiatry. 2014 Dec 1;171(12):1297-309. doi: 10.1176/appi.ajp.2014.12091165. Epub 2014 Oct 31.

PMID:
25220861
18.

Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials.

Kimura M, Tateno A, Robinson RG.

Am J Geriatr Psychiatry. 2003 May-Jun;11(3):320-7.

PMID:
12724111
19.

Fluoxetine versus other types of pharmacotherapy for depression.

Magni LR, Purgato M, Gastaldon C, Papola D, Furukawa TA, Cipriani A, Barbui C.

Cochrane Database Syst Rev. 2013 Jul 17;7:CD004185. Review.

PMID:
24353997
20.

A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender.

Joyce PR, Mulder RT, Luty SE, McKenzie JM, Rae AM.

Acta Psychiatr Scand. 2003 Jul;108(1):20-3.

PMID:
12807373
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk